Skip to main content

Table 4 Lipid profile in patients with myocardial infarction at 1 and 12 days of the myocardial infarction development

From: Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance

Variable

Control, n = 33

Patients with MI without IR, n = 46

Patients with MI and IR, n = 154

1-th day

12-th day

1-th day

12-th day

TC, mmol/liter

4.30 (3.51;6.10)

4.71 (3.91;6.45)

4.35 (3.90;5.00)

6.00 (5.21;7.01)a c

5.80 (4.90;7.01)c

TG, mmol/liter

1.13 (0.78;1.23)

1.15 (0.88;1.35)

1.83 (1.37;2.28)b

1.85 (1.31;2.51)a c

2.14 (1.48;2.97)b

HDL-C, mmol/liter

1.31 (1.02;1.72)

1.02 (0.82;1.17)

1.02 (0.83;1.24)

0.98 (0.74;1.30)a

0.96 (0.80;1.13)a

LDL-C, mmol/liter

2.03 (1.51;2.55)

2.13 (1.53;2.57)

2.45 (1.81;3.90)

3.10 (2.49;3.63)a c

3.35 (2.64;4.26)bc

VLDL-C, mmol/liter

0.44 (0.33;0.53)

0.52 (0.40;0.61)

0.83 (0.62;1.04)b

0.84 (0.59;1.14)a c

0.97 (0.67;1.35)b

apo B, g/L

1.02 (0.76;1.25)

1.00 (0.78;1.26)

1.28 (1.05;1.38)b

1.26 (1.07;1.51)a c

1.42 (1.04;1.69)b

apo A1, g/L

1.43 (1.29;1.73)

1.05 (0.93;1.49)a

1.54 (1.19;1.75)b

1.27 (1.15;1.43)a

1.28 (1.14;1.51)

apo-В/apo-А1

0.71 (0.59;1.01)

0.90 (0.72;1.16)

0.81 (0.69;1.09)

0.97 (0.81;1.25)a

0.94 (0.77;1.31)c

FFA, mcmol/L

0.20 (0.10;1.10)

1.20 (0.81;1.86)a

0.50 (0.43;0.69)b

1.80 (1.42;213)a c

0.57 (041;091)b

  1. Abbreviations: TC, Total cholesterol; TG, Triglycerides; HDL-C, Cholesterol high-density lipoproteins; LDL-C, Cholesterol low-density lipoproteins; VLDL-C, Cholesterol very-low-density lipoproteins; apo B, Apolipoprotein B; apo A1, Apolipoprotein A.
  2. Notes: areliable differences from control (p<0.05).
  3. creliable differences in the indicators on the 1 and 12days (р<0.05);
  4. breliable differences in the parameters between the groups (р<0.05).